Trastuzumab Deruxtecan in HER2-Low Breast Cancer. Schnog JB, Samson MJ, Duits AJ. N Engl J Med 2022;387:1143-1144.

Read + Share

Amedeo Smart

Independent Medical Education

Schnog JB, Samson MJ, Duits AJ. Trastuzumab Deruxtecan in HER2-Low Breast Cancer. N Engl J Med 2022;387:1143-1144.
PMID: 36130004